Caredx presents latest advancements at 12th congress of the international pediatric transplant association

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced its gold-level sponsorship and participation at the 12th congress of the international pediatric transplant association (ipta) taking place march 25-28, 2023, in austin, texas.
CDNA Ratings Summary
CDNA Quant Ranking